EQAPOL SARS CoV-2 Option 46
Research Grant
Administered By
Duke Human Vaccine Institute
Awarded By
National Institutes of Health
Start Date
September 30, 2022
End Date
September 29, 2024
Administered By
Duke Human Vaccine Institute
Awarded By
National Institutes of Health
Start Date
September 30, 2022
End Date
September 29, 2024